| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Department of Human Genetics (M.I., K.M.), Research Institute for Radiation Biology and Medicine, Department of Clinical Laboratory Medicine (H.N., T.O., M.K.), Department of Medicine and Molecular Science (T.I., N.M., K.C.), and Department of Cardiovascular Physiology and Medicine (M.Y.), Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Correspondence to Takafumi Ishida, MD, PhD, Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. E-mail ishidat{at}hiroshima-u.ac.jp
Angiotensin II (Ang II) stimulates protein synthesis in vascular smooth muscle cells (VSMCs), possibly secondary to regulatory changes at the initiation of mRNA translation. Mitogen-activated protein (MAP) kinase signalintegrating kinase-1 (Mnk1), a substrate of ERK and p38 MAP kinase, phosphorylates eukaryotic initiation factor 4E (eIF4E), an important factor in translation. The goal of the present study was to investigate the role of Mnk1 in Ang IIinduced protein synthesis and to characterize the molecular mechanisms by which Mnk1 and eIF4E is activated in rat VSMCs. Ang II treatment resulted in increased Mnk1 activity and eIF4E phosphorylation. Expression of a dominant-negative Mnk1 mutant abolished Ang IIinduced eIF4E phosphorylation. PD98059 or introduction of kinase-inactive MEK1/MKK1, but not SB202190 or kinase-inactive p38 MAP kinase, inhibited Ang IIinduced Mnk1 activation and eIF4E phosphorylation, suggesting that ERK, but not p38 MAP kinase, is required for Ang IIinduced Mnk1-eIF4E activation. Further, dominant-negative constructs for Ras, but not for Rho, Rac, or Cdc42, abolished Ang IIinduced Mnk1 activation. Finally, treatment of VSMCs with CGP57380, a novel specific kinase inhibitor of Mnk1, resulted in dose-dependent decreases in Ang IIstimulated phosphorylation of eIF4E, protein synthesis, and VSMC hypertrophy. In summary, these data demonstrated that (1) Ang IIinduced Mnk1 activation is mediated by the Ras-ERK cascade in VSMCs, and (2) Mnk1 is involved in Ang IImediated protein synthesis and hypertrophy, presumably through the activation of translation-initiation. The Mnk1-eIF4E pathway may provide new insights into molecular mechanisms involved in vascular hypertrophy and other Ang IImediated pathological states.
Key Words: angiotensin II protein synthesis Mnk1 vascular smooth muscle cells
This article has been cited by other articles:
![]() |
S. M. DeWire, J. Kim, E. J. Whalen, S. Ahn, M. Chen, and R. J. Lefkowitz {beta}-Arrestin-mediated Signaling Regulates Protein Synthesis J. Biol. Chem., April 18, 2008; 283(16): 10611 - 10620. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Rowlett, C. A. Chrestensen, M. Nyce, M. G. Harp, J. W. Pelo, F. Cominelli, P. B. Ernst, T. T. Pizarro, T. W. Sturgill, and M. T. Worthington MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G452 - G459. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells Hypertension, October 1, 2006; 48(4): 534 - 540. [Full Text] [PDF] |
||||
![]() |
N. Miho, T. Ishida, N. Kuwaba, M. Ishida, K. Shimote-Abe, K. Tabuchi, T. Oshima, M. Yoshizumi, and K. Chayama Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells Cardiovasc Res, November 1, 2005; 68(2): 289 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G Proud Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 403 - 413. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |